Chiba, Japan

Hideyuki Tomitori

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2014.



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hideyuki Tomitori in Stroke Diagnosis

Introduction

Hideyuki Tomitori is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of stroke detection. His innovative approach focuses on the measurement of specific biochemical markers to improve diagnostic accuracy.

Latest Patents

Tomitori holds a patent for a method of diagnosing apoplectic stroke and asymptomatic brain infarction using acrolein content. This invention provides a diagnostic method for stroke and asymptomatic cerebral infarction by measuring acrolein content, polyamine content, polyamine oxidase activity, or protein content of polyamine oxidase in plasma. The knowledge derived from this invention suggests the potential for preventing and inhibiting the progression of stroke and asymptomatic cerebral infarction by targeting polyamine oxidase.

Career Highlights

Throughout his career, Tomitori has worked with various organizations, contributing his expertise to advance medical technology. His work has been instrumental in developing methods that enhance the understanding and treatment of stroke-related conditions.

Collaborations

Tomitori has collaborated with notable professionals in his field, including Kazuei Igarashi and Shiro Ueda. These collaborations have further enriched his research and innovations.

Conclusion

Hideyuki Tomitori's contributions to stroke diagnosis through his innovative patent highlight the importance of biochemical markers in medical diagnostics. His work continues to pave the way for advancements in the prevention and treatment of stroke-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…